UK markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.70+0.06 (+0.90%)
At close: 04:00PM EDT
6.68 -0.02 (-0.30%)
After hours: 06:38PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts10101010
Avg. Estimate-0.91-0.88-3.64-1.66
Low estimate-1-1.04-3.94-4.19
High estimate-0.8-0.72-3.292.7
Year ago EPS-2.62-1.77-9.31-3.64
Revenue estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts991110
Avg. Estimate19.74M22.05M77.86M165.67M
Low estimate16M17.5M63M91.3M
High estimate21.6M25.07M83.96M274.16M
Year ago salesN/A15.4M78.45M77.86M
Sales growth (year/est)N/A43.20%-0.70%112.80%
Earnings history29/09/202130/12/202130/03/202229/06/2022
Est. EPS-2.8-2.27-1.04-0.93
Actual EPS-2.62-1.77-0.93-1.05
Difference0.180.50.11-0.12
Surprise %6.40%22.00%10.60%-12.90%
EPS trendCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Current estimate-0.91-0.88-3.64-1.66
7 days ago-0.91-0.88-3.64-1.66
30 days ago-0.9-0.88-3.63-1.63
60 days ago-0.9-0.88-3.63-1.63
90 days ago-0.9-0.88-3.63-1.63
EPS revisionsCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1111
Growth estimatesESPRIndustrySector(s)S&P 500
Current qtr.65.30%N/AN/AN/A
Next qtr.50.30%N/AN/AN/A
Current year60.90%N/AN/AN/A
Next year54.40%N/AN/AN/A
Next 5 years (per annum)16.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A